News Column

Luna Innovations Incorporated Reports Second Quarter 2014 Financial Results

August 12, 2014

Total revenues increase 8% compared to second quarter of 2013 and 17% compared to first quarter of 2014

ROANOKE, Va.--(BUSINESS WIRE)-- Luna Innovations Incorporated (NASDAQ: LUNA) today announced its financial results for the second quarter and six months ended June 30, 2014.

Total revenue for the second quarter of 2014 increased 8%, to $5.2 million compared to $4.8 million for the second quarter of 2013. Total revenue also increased 17% compared to the first quarter of 2014. Gross profit improved to $2.0 million, or 38% of total revenue, for the second quarter of 2014 from $1.8 million, or 37% of total revenue, for the second quarter of 2013. Operating expenses for the second quarter of 2014 also improved by $0.6 million, or 16%, compared to the second quarter of 2013. With increased revenues and lower operating expenses, the company's loss from continuing operations before income taxes of $1.0 million reflects an improvement of $0.7 million, or 43%, compared to the second quarter of 2013.

After recognition of discontinued operations, primarily associated with the sale of the company's medical shape sensing business in the first quarter of 2014, and income taxes, the company reported a net loss attributable to common stockholders of $0.9 million, or $0.06 per diluted common share, for the second quarter of 2014, compared to a net loss of $1.0 million, or $0.07 per diluted common share, in the same quarter last year. Adjusted EBITDA, a non-GAAP measure, which is earnings before interest, taxes, and non-cash expenses of share-based compensation, depreciation and amortization, improved to $(0.5) million for the second quarter of 2014, as compared to $(1.1) million for the second quarter of 2013.

Year to date, total revenue grew 9%, to $9.7 million for the first half of 2014 compared to $8.9 million for the first six months of 2013. Products and licensing revenue improved 9%, to $3.8 million for the first half of 2014 compared to $3.5 million in the first half of 2013. Technology development revenue increased 8%, to $5.9 million for the first six months of 2014 compared to $5.4 million in the first six months of 2013. Loss from continuing operations before income taxes for the first half of 2014 improved $1.0 million, or 27%, compared to the first half of 2013. After considering income from discontinued operations, which included the gain on sale of the company’s medical shape sensing business in 2014 and included the gain on sale of the company’s secure computing assets in addition to the operating contribution of the shape sensing business in 2013, net income attributable to common stockholders improved to $7.6 million, or $0.44 per diluted common share, for the first six months of 2014 compared to $1.8 million, or $0.11 per diluted common share for the first six months of 2013.

“Our revenue growth and improved bottom line, both year over year and for sequential quarters, demonstrate the value of our recent strategic initiatives for our stockholders," said My Chung, president and chief executive officer. "As we have recently stated, our primary focus continues to be on fiber optic sensing. By narrowing the number of key growth initiatives to a single one, we have been able to grow the business overall while reducing our expenses and maintaining the stronger balance sheet that resulted from our two previous strategic transactions. Going forward, we will continue to focus heavily on the enhancement of our fiber optic sensing products and the effective marketing of them to drive growth in future quarters.”

Second Quarter Financial and Business Summary

  • Total revenues grew to $5.2 million in the second quarter of 2014 compared to $4.8 million in the second quarter of 2013.
  • Technology development revenue increased by 15%, to $3.2 million, for the second quarter of 2014, from $2.8 million for the second quarter of 2013.
  • Products and licensing revenue was $2.0 million for the second quarter of 2014 flat relative to the second quarter of 2013, but up 12% compared to the first quarter of 2014.
  • Gross profit for the second quarter of 2014 improved to $2.0 million, or 38% of total revenues, compared to $1.8 million, or 37% of total revenues, for the second quarter of 2013.
  • Selling, general and administrative expenses decreased by 14% to $2.5 million, or 47% of total revenues for the second quarter of 2014, from $2.9 million, or 60% of total revenues, for the second quarter of 2013.
  • Total operating expenses decreased to $3.0 million, or 56% of total revenues, for the second quarter of 2014 from $3.5 million, or 73% of total revenue for the second quarter of 2013.
  • Adjusted EBITDA improved to $(0.5) million in the second quarter of 2014 from $(1.1) million in the second quarter of 2013.
  • Net loss attributable to common stockholders for the second quarter of 2014 improved to $0.9 million from $1.0 million for the second quarter of 2013.
  • Cash and cash equivalents totaled $14.7 million at June 30, 2014, as compared to $7.8 million at December 31, 2013 and $10.9 million at March 31, 2014. During the second quarter of 2014 the company received the second $6.0 million installment from Intuitive Surgical related to the sale of the company's medical shape sensing business.

    Six Months Ended June 30, 2014 Financial Summary

  • Total revenue increased by 9% to $9.7 million for the six months ended June 30, 2014 compared to $8.9 million for the six months ended June 30, 2013.
  • Technology development revenues increased by 8%, from $5.4 million for the six months ended June 30, 2013 to $5.9 million for the six months ended June 30, 2014.
  • Products and licensing revenue increased by 9%, from $3.5 million for the six months ended June 30, 2013 to $3.8 million for the six months ended June 30, 2014.
  • Gross profit for the six months ended June 30, 2014 increased by 20%, to $3.5 million, compared to a gross profit of $3.0 million for the six months ended June 30, 2013. Gross margin percentages increased to 36% of total revenue for the first six months of 2014 from 33% of total revenue for the first six months of 2013.
  • Selling, general and administrative expenses decreased to $5.2 million, representing 54% of total revenues for the six months ended June 30, 2014 compared to $5.5 million or 62% of total revenues for the six months ended June 30, 2013.
  • Total operating expenses decreased to $6.5 million, or 67% of total revenues, for the six months ended June 30, 2014, from $6.9 million or 78% of total revenues, for the six months ended June 30, 2013.
  • Adjusted EBITDA improved to $(2.0) million for the six months ended June 30, 2014 from $(2.7) million for the six months ended June 30, 2013.
  • Net income attributable to common stockholders improved to $7.6 million for the six months ended June 30, 2014, compared to net income attributable to common stockholders of $1.8 million for the six months ended June 30, 2013 largely the result of a net after-tax gain of $9.4 million realized on the sale of the company’s medical shape sensing business in the first quarter of 2014.

    Non-GAAP Measures

    In evaluating the operating performance of its business, Luna’s management excludes certain charges and credits that are required by generally accepted accounting principles (“GAAP”). These non-GAAP results provide useful information to both management and investors by excluding items that the company believes may not be indicative of its operating performance, because either they are unusual and the company does not expect them to recur in the ordinary course of its business or they are unrelated to the ongoing operation of the business in the ordinary course. These non-GAAP measures should be considered in addition to results and guidance prepared in accordance with GAAP, but should not be considered a substitute for, or superior to, GAAP results. The non-GAAP measures included in this press release have been reconciled to the nearest GAAP measure in the table following the financial statements attached to this press release.

    Conference Call Information

    As previously announced, Luna will conduct an investor conference call at 5:00 p.m. (EDT) today to discuss its financial results and business developments for the second quarter of 2014. The call can be accessed by dialing 877.703.6108 domestically or 857.244.7307 internationally prior to the start of the call. The participant access code is 30355723. Investors are advised to dial in at least five minutes prior to the call to register. The conference call will also be webcast live over the Internet. The webcast can be accessed by logging on to the “Investor Relations” section of the Luna website, www.lunainc.com, prior to the event. The webcast will be archived under the “Webcasts and Presentations” section of the Luna website for at least 30 days following the conference call.

    About Luna:

    Luna Innovations Incorporated (www.lunainc.com) is a public company composed of scientists, engineers, and business professionals developing and manufacturing a new generation of technologies and products. It has been successful in taking innovative technologies from applied research to product development and ultimately to the commercial market, driving breakthroughs in fields such as aerospace, automotive, telecommunications, healthcare, energy, and defense.

    Forward-Looking Statements:

    The statements in this release that are not historical facts constitute “forward-looking statements” made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. These statements include our expectations regarding the company’s future growth of the company’s fiber optic sensing products. Management cautions the reader that these forward-looking statements are only predictions and are subject to a number of both known and unknown risks and uncertainties, and actual results, performance, and/or achievements of the company may differ materially from the future results, performance, and/or achievements expressed or implied by these forward-looking statements as a result of a number of factors. These factors include, without limitation, failure of demand for the company’s products and services to meet expectations, technological challenges and those risks and uncertainties set forth in the company’s periodic reports and other filings with the Securities and Exchange Commission. Such filings are available at the SEC’s website at www.sec.gov and at the company’s website at www.lunainc.com. The statements made in this release are based on information available to the company as of the date of this release and Luna undertakes no obligation to update any of the forward-looking statements after the date of this release.

     
    Luna Innovations Incorporated
    Condensed Consolidated Balance Sheets
     
     
        June 30,

    2014

        December 31,

    2013

    (unaudited)
    Assets
    Current assets:
    Cash and cash equivalents $ 14,674,973 $ 7,778,541
    Accounts receivable, net 5,481,642 5,408,281
    Inventory, net 3,314,608 3,346,177
    Prepaid expenses 582,934 708,974
    Other current assets   70,207     70,208  
    Total current assets 24,124,364 17,312,181
    Property and equipment, net 1,939,607 2,060,709
    Intangible assets, net 188,816 288,475
    Other assets   5,126     42,710  
    Total assets $ 26,257,913   $ 19,704,075  
    Liabilities and stockholders’ equity

    Liabilities:

    Current Liabilities
    Current portion of long term debt obligation $ 1,375,000 $ 1,500,000
    Current portion of capital lease obligation 68,640 66,617
    Accounts payable 1,520,093 1,401,764
    Accrued liabilities 2,781,931 3,546,585
    Deferred credits   391,712     691,424  
    Total current liabilities 6,137,376 7,206,390
    Long-term debt obligation 625,000
    Long-term lease obligation   75,474     110,307  
    Total liabilities 6,212,850 7,941,697
    Commitments and contingencies
    Stockholders’ equity:
    Preferred stock 1,322 1,322
    Common stock, par value $ 0.001, 100,000,000 shares authorized, 15,003,901 and 14,527,335 shares issued at June 30, 2014 and December 31, 2013, respectively 15,299 14,842
    Less treasury stock at cost, 22,725 shares at June 30, 2014 and zero at December 31, 2013 (32,221 )
    Additional paid-in capital 63,503,505 62,756,571
    Accumulated deficit   (43,442,842 )   (51,010,357 )
    Total stockholders’ equity   20,045,063     11,762,378  
    Total liabilities and stockholders’ equity $ 26,257,913   $ 19,704,075  
     
     
    Luna Innovations Incorporated
    Condensed Consolidated Statements of Operations
     
     
        Three Months Ended

    June 30,

        Six Months Ended

    June 30,

    2014     20132014     2013
    (unaudited)(unaudited)
    Revenue:
    Technology development revenue $ 3,219,435 $ 2,807,296 $ 5,894,887 $ 5,434,537
    Products and licensing revenue   2,008,862   $ 2,023,668     3,805,291     3,501,795  
    Total revenue   5,228,297     4,830,964     9,700,178     8,936,332  
    Cost of revenue:
    Technology development costs 2,388,801 2,209,158 4,413,956 4,394,072
    Products and license costs   851,490     844,441     1,746,130     1,583,130  
    Total cost of revenue   3,240,291     3,053,599     6,160,086     5,977,202  
    Gross Profit   1,988,006     1,777,365     3,540,092     2,959,130  
    Operating expense:
    Selling, general and administrative 2,466,626 2,875,461 5,221,704 5,538,569
    Research, development and engineering   484,509     641,790     1,233,663     1,401,781  
    Total operating expense   2,951,135     3,517,251     6,455,367     6,940,350  
    Operating loss   (963,129 )   (1,739,886 )   (2,915,275 )   (3,981,220 )
    Other income/(expense):
    Other income, net 29,325 94,990 111,431 193,144
    Interest expense   (27,302 )   (49,781 )   (59,667 )   (107,960 )
    Total other income   2,023     45,209     51,764     85,184  
    Loss from continuing operations before income taxes (961,106 ) (1,694,677 ) (2,863,511 ) (3,896,036 )
    Income tax (benefit)/expense   (375,983 )   (659,341 )   (1,145,173 )   (1,541,768 )
    Loss from continuing operations   (585,123 )   (1,035,336 )   (1,718,338 )   (2,354,268 )
    Gain on sale, net of $0.4 million, $0.3 million, $1.3 million and $1.3 million of related income taxes, respectively (330,716 ) (364,338 ) 9,370,799 3,682,159
    Operating (loss)/ income from discontinued operations, net of $0.0, $0.3 million, $0.0 million and $0.3 million related income tax, respectively       447,592     (28,076 )   505,624  
    Discontinued operations, net of tax   (330,716 )   83,254     9,342,723     4,187,783  
    Net (loss)/income (915,839 ) (952,082 ) 7,624,385 1,833,515
    Preferred stock dividend   27,334     26,366     56,870     49,995  
    Net (loss)/income attributable to common stockholders $ (943,173 ) $ (978,448 ) $ 7,567,515   $ 1,783,520  
    Net loss per share from continuing operations:
    Basic $ (0.04 ) $ (0.07 ) $ (0.12 ) $ (0.17 )
    Diluted $ (0.04 ) $ (0.07 ) $ (0.12 ) $ (0.17 )
    Net (loss)/income per share from discontinued operations:
    Basic $ (0.02 ) $ 0.01 $ 0.63 $ 0.29
    Diluted $ (0.02 ) $   $ 0.54   $ 0.25  
    Net (loss)/income per share attributable to common stockholders:
    Basic $ (0.06 ) $ (0.07 ) $ 0.51 $ 0.13
    Diluted $ (0.06 ) $ (0.07 ) $ 0.44   $ 0.11  
    Weighted average common shares and common equivalent shares outstanding:
    Basic 14,817,084 14,362,494 14,722,474 14,206,598
    Diluted 14,817,084 16,723,796 17,201,639 16,558,246
     
     
    Luna Innovations Incorporated
    Condensed Consolidated Statements of Cash Flows
     
     
        Six months ended

    June 30,

    2014     2013
    (unaudited)
    Cash used in operating activities
    Net income $ 7,624,385 $ 1,833,515
    Adjustments to reconcile net income (loss) to net cash used in operating activities
    Depreciation and amortization 336,564 489,244
    Share-based compensation 488,593 618,084
    Warrant expense
    Gain on sale of discontinued operations, net of income taxes (9,370,799 ) (3,868,114 )
    Allowance for doubtful accounts or bad debt expense 124,810
    Tax benefit from utilization of net operating loss carryforward (1,163,301 ) (1,021,538 )
    Change in assets and liabilities:
    Accounts receivable (73,857 ) 834,122
    Inventory (6,796 ) (309,217 )
    Other current assets 72,141 (40,647 )
    Other assets 37,584 72,584
    Accounts payable and accrued expenses (761,149 ) 174,916
    Deferred credits   (299,712 )   (221,553 )
    Net cash used in operating activities   (3,116,347 )   (1,313,794 )
    Cash flows used in investing activities
    Acquisition of property and equipment (135,136 ) (69,108 )
    Intangible property costs (138,118 ) (145,858 )
    Proceeds from sale of discontinued operations, net of fees   10,927,268     4,522,460  
    Net cash provided by/(used in) investing activities   10,654,014     4,307,494  
    Cash flows used in financing activities
    Payments on capital lease obligations (32,810 ) (26,641 )
    Payment of debt obligations (750,000 ) (625,000 )
    Purchase of treasury stock (32,221 )
    Proceeds from the exercise of options and warrants   173,796     60,349  
    Net cash used in financing activities   (641,235 )   (591,292 )
    Net increase in cash or cash equivalents 6,896,432 2,402,408
    Cash and cash equivalents, beginning of period   7,778,541     6,340,461  
    Cash and cash equivalents, end of period $ 14,674,973   $ 8,742,869  
     
     
    Luna Innovations Incorporated
    Reconciliation of Net Income/(Loss) to EBITDA and Adjusted EBITDA
     
     
        Three Months Ended

    June 30,

        Six Months Ended

    June 30,

    2014     20132014     2013
    (unaudited)(unaudited)
    Net income/(loss) $ (915,839 ) $ (952,082 ) $ 7,624,385 $ 1,833,515
    Less (loss)/income from discontinued operations, net of income taxes   (330,716 )   83,254     9,342,723    

    4,187,783

     
    Loss from continuing operations (585,123 ) (1,035,336 ) (1,718,338 )

    (2,354,268

    )
    Interest expense 27,302 49,781 59,667 107,960
    Tax (benefit) expense (375,983 ) (659,341 ) (1,145,173 ) (1,541,768 )
    Depreciation and amortization   134,259     260,979     336,564     489,244  
    EBITDA (799,545 ) (1,383,917 ) (2,467,280 )

    (3,298,832

    )
    Share-based compensation 257,654 304,568 488,593 618,084
    Adjusted EBITDA $ (541,891 ) $ (1,079,349 ) $ (1,978,687 ) $

    (2,680,748

    )
     





    Luna Innovations Incorporated

    Investor Contact:

    Dale Messick, CFO

    Phone: 1.540.769.8400

    Email: IR@lunainc.com


    Source: Luna Innovations Incorporated


  • For more stories on investments and markets, please see HispanicBusiness' Finance Channel



    Source: Business Wire


    Story Tools






    HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters